Latest Breaking News On - Niranjan kanesa thasan - Page 1 : comparemela.com

Chief Medical Officer Niranjan Kanesa-thasan Sells 11,884 Shares of Icosavax Inc (ICVX)

According to a recent SEC filing, Niranjan Kanesa-thasan, the Chief Medical Officer of Icosavax Inc (NASDAQ:ICVX), sold 11,884 shares of the company on December 20, 2023.

Icosavax incIopharmaceutical companyChief medical officerNiranjan kanesa thasanNsider transaction

Icosavax (ICVX) Reports Positive Topline Interim Phase 2 Results for IVX-A12

Icosavax (ICVX) Reports Positive Topline Interim Phase 2 Results for IVX-A12
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Niranjan kanesa thasanAdam simpsonIcosavax incChief executive officerChief medical officer

Icosavax (NASDAQ:ICVX) Given Outperform Rating at Oppenheimer

Oppenheimer reissued their outperform rating on shares of Icosavax (NASDAQ:ICVX – Free Report) in a report published on Monday, Benzinga reports. They currently have a $25.00 target price on the stock. Icosavax Price Performance Shares of ICVX opened at $7.54 on Monday. Icosavax has a 12 month low of $2.28 and a 12 month high […]

Adamk simpsonNiranjan kanesa thasanYork mellon corpMetlife investment managementSwiss national bankJpmorgan chase coCitigroup incSecurities exchange commissionIcosavax company profileIcosavax incFree reportGet free reportExchange commissionNational bankNew york mellon corpLife investment management

Icosavax, Inc (NASDAQ:ICVX) Short Interest Down 15 3% in July

Icosavax, Inc (NASDAQ:ICVX) Short Interest Down 15 3% in July
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Niranjan kanesa thasanCassia cearleyPricet rowe associates incT rowe price investment management incSecurities exchange commissionIcosavax incPlatinum investment management ltdCrossover managementGet free reportExchange commissionRowe price investment managementPlatinum investment managementInvestment managementStock downIcosavax daily

Icosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination Potential

Icosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination Potential
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLaurence wattsJessica yinglingAdam simpsonNiranjan kanesa thasanExchange commissionUniversity of washingtonIcosavax incGilmartin groupLittle dog communications incInstitute for protein designReports positiveMonth durability dataInitial evidenceRespiratory syncytial virusChief executive officer